Publications

Title

Author

Year

Book Review: Maya Goldenberg, Vaccine Hesitancy: Public Trust, Expertise, and the War on Science Alex de Waal, New Pandemics, Old Politics: Two Hundred Years of War on Disease and Its Alternatives.

LARSON, HJ;

2022

Public Understanding of Science, (2022).31 6 10.1177/09636625221088066.

The impact of alternative delivery strategies for novel tuberculosis vaccines in low- and middle-income countries: a modelling study.

Clark, R; Mukandavire, C; Portnoy, A; WEERASURIYA, C; Deol, A; Scarponi, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, R; Menzies, N; WHITE, R;

2022

medRxiv (2022). 10.1101/2022.04.16.22273762.

Human papillomavirus vaccine communication materials for young people in English-speaking countries: A content analysis.

Fisher, H; CHANTLER, T; MOUNIER-JACK, S; Audrey, S;

2022

Health education journal, (2022).81 5 10.1177/00178969221092135.

In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-Analysis.

Bolotin, S; Osman, S; Hughes, SL; Ariyarajah, A; Tricco, AC; Khan, S; Li, L; Johnson, C; Friedman, L; Gul, N; Jardine, R; Faulkner, M; Hahné, SJ M; Heffernan, JM; Dabbagh, A; Rota, PA; Severini, A; JIT, M; Durrheim, DN; Orenstein, WA; Moss, WJ; FUNK, S; Turner, N; Schluter, W; Jawad, JS; ... Crowcroft, NS.

2022

The Journal of infectious diseases, (2022).226 7 10.1093/infdis/jiac039.

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?.

DOCKRELL, HM; McShane, H;

2022

EBioMedicine, (2022).79, 10.1016/j.ebiom.2022.103993.

Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis.

LIU, Y; PEARSON, CA B; Sandmann, FG; BARNARD, RC; Kim, J-H; CMMID COVID-19 Working Group,; FLASCHE, S; JIT, M; ABBAS, K;

2022

The Lancet Regional Health - Europe, (2022).17, 10.1016/j.lanepe.2022.100381.

Operational lessons learned in conducting an international study on pharmacovigilance in pregnancy in resource-constrained settings: The WHO Global Vaccine safety Multi-Country collaboration project.

Sharan, A; Jahagirdar, S; Stuurman, AL; Elango, V; Riera-Montes, M; Kumar Kashyap, N; Kumar Arora, N; Mathai, M; MANGTANI, P; Devlieger, H; Anderson, S; Whitaker, B; Wong, H-L; Cutland, CL; Guillard Maure, C; WHO Global Vaccine Safety Multi-Country Collaborat,;

2022

VACCINE: X, (2022).11, 10.1016/j.jvacx.2022.100160.

The potential cost-effectiveness of HPV vaccination among girls in Mongolia.

Luvsan, M-E; Vodicka, E; Jugder, U; Tudev, U; CLARK, A; Groman, D; Otgonbayar, D; Demberelsuren, S; LaMongtagne, DS; Pecenka, C;

2022

Vaccine: X, (2022).11, 10.1016/j.jvacx.2022.100161.

Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa.

MCCREESH, N; Karat, AS; GOVENDER, I; BAISLEY, K; Diaconu, K; Yates, TA; HOUBEN, RM; Kielmann, K; GRANT, AD; WHITE, R;

2022

BMJ global health, (2022).7 4 10.1136/bmjgh-2021-007136.

Development of a multicomponent intervention to increase parental vaccine confidence and young people's access to the universal HPV vaccination programme in England: protocol for a co-design study.

Fisher, H; CHANTLER, T; Denford, S; Finn, A; Hickman, M; MOUNIER-JACK, S; Roderick, M; Tucker, L; Yates, J; Audrey, S;